Search research articles
Contact Us
Filters
Showing results (151-160 of 167) with videos related to
Page
of 17
Sort By:
The Journal of Clinical Investigation
|
June 21, 2021
Cytomegalovirus mediates expansion of IL-15-responsive innate-memory cells with SIV killing function
Gema Méndez-Lagares, Ning Chin, W L William Chang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 3, 2017
Prospective evaluation of serum anti-Müllerian hormone dynamics in 250 women of reproductive age treated with chemotherapy for breast cancer
A Dezellus, P Barriere, M Campone, et al.
Plos One
|
September 28, 2017
Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-B
Miriam Rosás-Umbert, Beatriz Mothe, Marc Noguera-Julian, et al.
Eclinicalmedicine
|
July 18, 2019
Therapeutic Vaccination Refocuses T-cell Responses Towards Conserved Regions of HIV-1 in Early Treated Individuals (BCN 01 study)
Beatriz Mothe, Christian Manzardo, Alvaro Sanchez-Bernabeu, et al.
Clinical and Experimental Immunology
|
April 10, 2026
Immunological Dysfunction Associated with SARS-CoV-2 Persistence in Immunocompromised Patients
Ida M Johannsen, Line K Vibholm, Giacomo S Frattari, et al.
Eclinicalmedicine
|
January 21, 2020
Corrigendum to 'Therapeutic vaccination refocuses T-cell responses towards conserved regions of HIV-1 in early treated individuals (BCN 01 study)' EClinicalMedicine 11 (2019) 65-80
Beatriz Mothe, Christian Manzardo, Alvaro Sanchez-Bernabeu, et al.
Nature Communications
|
October 30, 2022
Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8<sup>+</sup> T cell immunity
Miriam Rosás-Umbert, Jesper D Gunst, Marie H Pahus, et al.
Nature Medicine
|
October 27, 2022
Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial
Lucia Bailón, Anuska Llano, Samandhy Cedeño, et al.
Pharmacology Research & Perspectives
|
January 11, 2024
A systematic review on experimental studies about patient adherence to treatment
Frans Folkvord, Ana Roca-Umbert Würth, Karlijn van Houten, et al.
Ebiomedicine
|
March 24, 2022
Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcome
Bruna Oriol-Tordera, Anna Esteve-Codina, María Berdasco, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 167) with videos related to
Sort By:
Page
of 17
The Journal of Clinical Investigation
|
June 21, 2021
Cytomegalovirus mediates expansion of IL-15-responsive innate-memory cells with SIV killing function
Gema Méndez-Lagares, Ning Chin, W L William Chang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 3, 2017
Prospective evaluation of serum anti-Müllerian hormone dynamics in 250 women of reproductive age treated with chemotherapy for breast cancer
A Dezellus, P Barriere, M Campone, et al.
Plos One
|
September 28, 2017
Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-B
Miriam Rosás-Umbert, Beatriz Mothe, Marc Noguera-Julian, et al.
Eclinicalmedicine
|
July 18, 2019
Therapeutic Vaccination Refocuses T-cell Responses Towards Conserved Regions of HIV-1 in Early Treated Individuals (BCN 01 study)
Beatriz Mothe, Christian Manzardo, Alvaro Sanchez-Bernabeu, et al.
Clinical and Experimental Immunology
|
April 10, 2026
Immunological Dysfunction Associated with SARS-CoV-2 Persistence in Immunocompromised Patients
Ida M Johannsen, Line K Vibholm, Giacomo S Frattari, et al.
Eclinicalmedicine
|
January 21, 2020
Corrigendum to 'Therapeutic vaccination refocuses T-cell responses towards conserved regions of HIV-1 in early treated individuals (BCN 01 study)' EClinicalMedicine 11 (2019) 65-80
Beatriz Mothe, Christian Manzardo, Alvaro Sanchez-Bernabeu, et al.
Nature Communications
|
October 30, 2022
Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8<sup>+</sup> T cell immunity
Miriam Rosás-Umbert, Jesper D Gunst, Marie H Pahus, et al.
Nature Medicine
|
October 27, 2022
Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial
Lucia Bailón, Anuska Llano, Samandhy Cedeño, et al.
Pharmacology Research & Perspectives
|
January 11, 2024
A systematic review on experimental studies about patient adherence to treatment
Frans Folkvord, Ana Roca-Umbert Würth, Karlijn van Houten, et al.
Ebiomedicine
|
March 24, 2022
Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcome
Bruna Oriol-Tordera, Anna Esteve-Codina, María Berdasco, et al.
Page
of 17